SAVI, Monia
 Distribuzione geografica
Continente #
NA - Nord America 5.135
AS - Asia 4.298
EU - Europa 3.348
SA - Sud America 482
AF - Africa 152
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 13.430
Nazione #
US - Stati Uniti d'America 5.004
SG - Singapore 1.469
CN - Cina 1.394
VN - Vietnam 725
IT - Italia 622
FI - Finlandia 596
IE - Irlanda 477
DE - Germania 411
SE - Svezia 391
BR - Brasile 359
HK - Hong Kong 287
UA - Ucraina 201
FR - Francia 182
NL - Olanda 107
ZA - Sudafrica 98
CA - Canada 91
GB - Regno Unito 90
TR - Turchia 87
IN - India 61
AT - Austria 56
BD - Bangladesh 52
RU - Federazione Russa 52
BE - Belgio 49
AR - Argentina 43
JP - Giappone 29
PH - Filippine 27
MX - Messico 26
IQ - Iraq 23
KR - Corea 23
CZ - Repubblica Ceca 22
EC - Ecuador 22
CO - Colombia 21
PL - Polonia 21
CH - Svizzera 17
TH - Thailandia 17
PK - Pakistan 16
ES - Italia 15
VE - Venezuela 14
ID - Indonesia 12
LT - Lituania 12
MA - Marocco 11
EG - Egitto 9
UZ - Uzbekistan 9
EU - Europa 8
PY - Paraguay 8
TW - Taiwan 8
AU - Australia 7
DZ - Algeria 7
KE - Kenya 7
AZ - Azerbaigian 6
IR - Iran 6
NP - Nepal 6
SK - Slovacchia (Repubblica Slovacca) 6
AE - Emirati Arabi Uniti 5
CI - Costa d'Avorio 5
CL - Cile 5
ET - Etiopia 5
OM - Oman 5
PE - Perù 5
QA - Qatar 5
SA - Arabia Saudita 5
EE - Estonia 4
IL - Israele 4
JM - Giamaica 4
JO - Giordania 4
UY - Uruguay 4
AL - Albania 3
CR - Costa Rica 3
LB - Libano 3
NG - Nigeria 3
RS - Serbia 3
SI - Slovenia 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
KG - Kirghizistan 2
NI - Nicaragua 2
PR - Porto Rico 2
RO - Romania 2
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
GA - Gabon 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
MN - Mongolia 1
PA - Panama 1
PS - Palestinian Territory 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
ZW - Zimbabwe 1
Totale 13.430
Città #
Singapore 759
Ashburn 570
Dallas 507
Dublin 477
Chandler 434
San Jose 372
Ann Arbor 306
Beijing 301
Santa Clara 274
Hong Kong 272
Jacksonville 266
Dearborn 248
Parma 235
Ho Chi Minh City 189
Boardman 177
Nanjing 159
Hanoi 138
New York 130
Wilmington 124
Johannesburg 93
Shanghai 88
Bremen 79
Los Angeles 79
Princeton 79
Hefei 74
Munich 74
Helsinki 70
Izmir 69
Lauterbourg 66
Seattle 64
Jinan 61
Padova 58
Brussels 48
Tulsa 47
Vienna 47
Nanchang 45
Shenyang 43
Kunming 40
Toronto 40
San Mateo 39
Da Nang 38
Dong Ket 38
Des Moines 36
Haiphong 34
Hebei 33
Council Bluffs 32
São Paulo 32
Changsha 31
Columbus 27
London 27
Marseille 27
Buffalo 26
The Dalles 26
Turku 26
Frankfurt am Main 25
Woodbridge 25
Houston 24
Falkenstein 23
Montreal 23
Moscow 23
Tianjin 23
Zhengzhou 22
Milan 21
Tokyo 21
Guangzhou 19
Ningbo 18
Orem 17
Warsaw 17
Brooklyn 16
Nuremberg 16
Seoul 16
Bologna 15
Denver 15
Ottawa 15
Baghdad 14
Biên Hòa 14
Chennai 14
Jiaxing 14
Boston 13
Falls Church 13
Lanzhou 13
Redmond 13
Taizhou 13
Fremont 12
Hangzhou 12
Hải Dương 12
Quito 12
Belo Horizonte 11
Chicago 11
Rio de Janeiro 11
Haikou 10
Jakarta 10
Pune 10
Rome 10
Amsterdam 9
Atlanta 9
Brno 9
Can Tho 9
Curitiba 9
Modena 9
Totale 8.364
Nome #
Cobalt oxide nanoparticles induce oxidative stress and alter electromechanical function in rat ventricular myocytes 445
Effects of standardized green tea extract and its main component, EGCG, on mitochondrial function and contractile performance of healthy rat cardiomyocytes 269
Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart 260
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol 259
Cardiac effects of acute exposure to titanium dioxide nanoparticles: electrophysiological characterization 255
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 253
5-(Hydroxyphenyl)-γ-Valerolactone-Sulfate, a Key Microbial Metabolite of Flavan-3-ols, Is Able to Reach the Brain: Evidence from Different in Silico, In Vitro and In Vivo Experimental Models 252
Cardiac stem cell disease in diabetic cardiomyopathy: perspectives for preventing cardiac morpho-functional remodelling 242
Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction. 242
Bioaccumulation of Resveratrol Metabolites in Myocardial Tissue is Dose-Time Dependent and Related to Cardiac Hemodynamics in Diabetic Rats 236
Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue 235
Long-Term Oral Administration of Theaphenon-E Improves Cardiomyocyte Mechanics and Calcium Dynamics by Affecting Phospholamban Phosphorylation and ATP Production 224
Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats 222
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors 215
In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation 212
Not just a witness: Highlighting the utility of witness social defeat stress for the examination of neuroimmune-cardiovascular interactions across diverse populations 211
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes 203
L’autofagia coinvolge i cardiomiociti e le cellule progenitrici nella cardiomiopatia indotta da imatinib mesilato 200
Effects of acute exposure to titanium dioxide (TiO2) nanoparticles on ventricular cardiomyocytes: mechanical and cytotoxic characterization. 196
Decline of cardiomyocyte contractile performance and bioenergetic function in socially stressed male rats 195
Repeated witness social stress causes cardiomyocyte contractile impairment and intracellular Ca2+ derangement in female rats 194
Lymphangiogenesis in genetically determined hypertrophic obstructive cardiomyopathy 186
Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling. 184
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 182
Nanoparticles exposure: In-vitro and in-vivo investigation to evaluate cardiovascu1ar risk factors in normal and failing cardiac tissue [Esposizione a nanoparticelle: Studi in-vitro ed in-vivo per valutare i fattori di rischio cardiovascolari in cuori normali e patologici] 175
Amelioration of cardiac electrical performance following stem cell based regenerative therapies, in infarcted rat heart 175
The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice. 174
Elevated miR-34a expression and altered transcriptional profile are associated with adverse electromechanical remodeling in the heart of male rats exposed to social stress 172
Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease? 169
Microsfere polimeriche funzionalizzate per terapie rigenerative cardiache mediate da cellule staminali. Test di biocompatibilità in vitro e in vivo. 168
Repair of chronic myocardial infarction (MI) induced by mobilization of cardiac progenitor cells (CPCs) via local delivery of hapatocyte growth factor (HGF) and insulin-like growth factor-1 (IGF-1) is not proarrhythmic. 167
Development and validation of an high performance liquidchromatography–tandem mass spectrometry method for the determination of imatinib in rat tissues 166
Mobilization of cardiac progenitor cells by Hepatocyte Growth Factor (HGF) and Insulin-like Growth Factor-1 (IGF-1) for repairing chronic myocardial infarction (MI) is not proarrhytmic. 166
Cardiac regeneration by pharmacologically active microcarriers releasing growth factors and/or transporting adipose-derived stem cells 165
Trimethylamine-N-Oxide (TMAO)-Induced Impairment of Cardiomyocyte Function and the Protective Role of Urolithin B-Glucuronide 164
Hystone deacetylase inhibitors (HDACi) ameliorate cardiac elctrical competence in mdx mouse model of Duchenne muscular dystrophy (DMD). 163
Imatinib Mesylate Induced Cardiotoxicity: a Cardiac Progenitor Cell Disease? 157
Deacetylase inhibitors reduce cardiac arrhythmogenesis in mdx mouse model of duchenne muscular dystrophy (DMD). 156
Cardiac regeneration by pharmacologically active microcarriers releasing growth factors and/or transporting adipose-derived stem cells 156
Competenza funzionale elettrica del cuore rigenerato mediante mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardico cronico. 155
Dissecting the cellular mechanisms of cardiotoxicity by anthracycline and tyrosine kinase inhibitors 155
Potential involvement of cardiac and bone marrow vascular progenitors in imatinib induced cardiovascular toxicity 153
Cardiac electromechanical performance following stem cell based regenerative therapies in infarcted rat heart. 153
Electro-mechanical competence of regenerated heart in stem cell based therapy of myocardial infarction in rat model. 152
Changes in actin isoform expression prior to the transition from compensated pressure-overload cardiac hypertrophy to decompensation. 147
Resident cardiac stem cells. 145
High-resolution X-ray microtomography for three-dimensional imaging of cardiac progenitor cell homing in infarcted rat hearts 144
Stem cells and myocardial regeneration 142
Tyrosine kinase cardiotoxicity: ultrastructural analysis of imatinib mesylate induced cardiomyopathy 140
Competenza funzionale elettrica del cuore rigenerato mediante mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardico cronico 137
Imatinib mesylate induced cardiotoxicity: a cardiac progenitor cell disease? 137
Deacetylase Inhibitors ameliorate cardiac electrical competence in MDX mouse model of Duchenne muscular dystrophy (DMD). 136
High-Resolution X-Ray Microtomography for Three-Dimensional Visualization of Cardiac Progenitor Cells Homing in Infarcted Rat Hearts 136
Functional recovery of the infarcted heart mediated by pharmacologically active microcarriers conveying human adipose-derived stem cells and/or releasing growth factors 135
Urolithins at physiological concentrations affect the levels of pro-inflammatory cytokines and growth factor in cultured cardiac cells in hyperglucidic conditions 134
Mobilization of cardiac progenitor cells by hepatocyte growth factor and insulin-like growth factor-1 for repairing chronic myocardial infarction is not proarrhythmic. 132
Phase-contrast microtomography: are the tracers necessary for stem cell tracking in infarcted hearts? 131
Alpha-skeletal actin expression correlate with the degree of pressure overload cardiac hypertrophy, preserving cardiac function. 130
Modulation of actin isoform expression before the transition from experimental compensated pressure-overload cardiac hypertrophy to decompensation. 129
Electromechanical competence of the myocardium regenerated by growth factors and cell therapy in ischemic cardiomyopathy. 127
Enhanced engraftment and repairing ability of human adipose-derived stem cells, conveyed by pharmacologically active microcarriers continuously releasing HGF and IGF-1, in healing myocardial infarction in rats 127
Studio in vitro ed in vivo della biocompatibilità di PAM (pharmacologically active microcarriers) come substrato per la rigenerazione miocardica 126
Changes in actin isoform expression are involved in the transition from compensated pressure-overload cardiac hypertrophy to ventricular dysfunction 126
Valutazione dell’efficacia rigenerativa della mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardio 125
Changes in actin isoform expression are involved in the transition from compensated pressure-overload cardiac hypertrophy to ventricular dysfunction 125
Electrical stability of infarcted rat hearts following treatment with stem cells 122
Alpha-skeletal actin expression correlate with the degree of pressure overload cardiac hypertrophy, preserving cardiac function 121
Effects of the alpha2-adrenergic/DA2-dopaminergic agonist CHF-1024 in preventing ventricular arrhythmogenesis and myocyte electrical remodeling, in a rat model of pressure-overload cardiac hypertrophy 119
Early antioxidant treatment with resveratrol: a new therapeutic approach for preventing diabetic cardiomyopathy 116
Electro-mechanical competence of regenerated heart in stem cell based therapy of myocardial infarction in rat model 116
Histone deacetylase inhibitors ameliorate cardiac electrical competence in dystrophic mice. 116
Hdac inhibition improves the sarcoendoplasmic reticulum Ca2+-ATPase activity in cardiac myocytes 115
Pharmacologically active microcarriers conveying human adipose-derived stem cells and/or releasing growth factors in myocardial regeneration 112
Role of cardiac lymphatic vessels in ischemic and drug induced cardiomyopathy 111
Electrical competence of newly formed tissue in stem cell based regeneration of myocardial infarction in rat model 109
Stem cell based regenerative therapies in healed myocardial infarction 105
In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats 103
High-resolution X-ray microtomography for three-dimensional visualization of Cardiac Progenitor Cells Homing in infarcted rat hearts. 99
Valutazione dell’efficacia rigenerativa della mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardio. 98
Exogenous high-mobility group box 1 protein (hmgb1) ameliorates cardiac electrical performance in infarcted rat heart 89
Uso di microsfere polimeriche funzionalizzate per terapie rigenerative cardiache mediate da cellule staminali. Test di biocompatibilità in modelli di ratto di infarto miocardico 87
Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves myocyte proliferation and changes in intercellular coupling 87
Electrical competence of infarcted heart following stem cell based regenerative therapy, in a rat model 87
Totale 13.556
Categoria #
all - tutte 39.350
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.350


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021175 0 0 0 0 0 0 0 0 0 32 85 58
2021/2022444 21 31 10 18 14 19 58 46 14 30 36 147
2022/20231.854 168 172 120 141 220 199 15 123 575 4 71 46
2023/2024811 37 66 24 13 58 252 78 54 22 53 83 71
2024/20252.236 25 101 114 213 278 255 112 117 222 173 208 418
2025/20264.572 387 691 535 389 615 251 540 183 649 332 0 0
Totale 13.556